Clinical trial
Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy
NCT04125329 is registered in ClinicalTrials.gov with Yan'an Affiliated Hospital of Kunming Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy
- Lead sponsor
- Yan'an Affiliated Hospital of Kunming Medical University
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- April 1, 2020
- Completion date
- September 1, 2024
- Enrollment
- 15 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic nephropathy, mesenchymal stem cells